[
  {
    "title": "【龙虎榜】海辰药业12月29日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/29180137246961.shtml",
    "datetime": "2022-12-29 18:01:54",
    "code": "300584"
  },
  {
    "title": "A股异动 | 海辰药业跌3% 公司未取得熊去氧胆酸原料药及制剂的药品注册批件",
    "href": "http://stock.jrj.com.cn/2022/12/09105737200655.shtml",
    "datetime": "2022-12-09 10:57:30",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：未取得熊去氧胆酸原料药及制剂的药品注册批件",
    "href": "http://stock.jrj.com.cn/2022/12/08205837199551.shtml",
    "datetime": "2022-12-08 20:58:23",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业12月8日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/08180437198952.shtml",
    "datetime": "2022-12-08 18:04:42",
    "code": "300584"
  },
  {
    "title": "海辰药业：公司及子公司未取得熊去氧胆酸原料药及制剂药品注册批件",
    "href": "http://stock.jrj.com.cn/2022/12/08171837198657.shtml",
    "datetime": "2022-12-08 17:18:03",
    "code": "300584"
  },
  {
    "title": "海辰药业：公司及子公司未取得熊去氧胆酸原料药及制剂药品注册批件",
    "href": "http://stock.jrj.com.cn/2022/12/08165937198567.shtml",
    "datetime": "2022-12-08 16:59:53",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：孟鲁司特钠咀嚼片获批上市",
    "href": "http://stock.jrj.com.cn/2022/12/08155137198320.shtml",
    "datetime": "2022-12-08 15:51:01",
    "code": "300584"
  },
  {
    "title": "海辰药业：孟鲁司特钠咀嚼片获药品注册批件",
    "href": "http://stock.jrj.com.cn/2022/12/08154737198256.shtml",
    "datetime": "2022-12-08 15:47:25",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业12月7日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/07180337195642.shtml",
    "datetime": "2022-12-07 18:03:52",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：向深交所申请中止审核创业板向特定对象发行股票申请文件",
    "href": "http://stock.jrj.com.cn/2022/11/03192737110718.shtml",
    "datetime": "2022-11-03 19:27:11",
    "code": "300584"
  },
  {
    "title": "海辰药业2022年前三季度净利2008.25万同比下滑28.87% 信用减值损失增加",
    "href": "http://stock.jrj.com.cn/2022/10/25185037082671.shtml",
    "datetime": "2022-10-25 18:50:56",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：达比加群酯胶囊获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2022/10/20154237069957.shtml",
    "datetime": "2022-10-20 15:42:46",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)半年度净利润1772.15万元 同比下降16.16%",
    "href": "http://stock.jrj.com.cn/2022/08/25170436936052.shtml",
    "datetime": "2022-08-25 17:04:10",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：定增申请获深交所受理",
    "href": "http://stock.jrj.com.cn/2022/08/23220036928089.shtml",
    "datetime": "2022-08-23 22:00:19",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：注射用替加环素拟中选第七批国采",
    "href": "http://stock.jrj.com.cn/2022/07/13171436807796.shtml",
    "datetime": "2022-07-13 17:14:20",
    "code": "300584"
  },
  {
    "title": "蹭完新冠药再蹭新能源，海辰药业葫芦里卖的什么药？",
    "href": "http://stock.jrj.com.cn/2022/06/17084936736665.shtml",
    "datetime": "2022-06-17 08:49:31",
    "code": "300584"
  },
  {
    "title": "海辰药业：拟定增募资不超4亿元，用于抗新冠原料药关键中间体建设项目等",
    "href": "http://stock.jrj.com.cn/2022/06/13113036723381.shtml",
    "datetime": "2022-06-13 11:30:46",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)拟定增募资不超4亿元 用于肥东固体制剂建设项目等等",
    "href": "http://stock.jrj.com.cn/2022/06/10193536720295.shtml",
    "datetime": "2022-06-10 19:35:33",
    "code": "300584"
  },
  {
    "title": "海辰药业：拟定增募资不超4亿元 用于150吨抗新冠原料药关键中间体建设项目等",
    "href": "http://stock.jrj.com.cn/2022/06/10192836720265.shtml",
    "datetime": "2022-06-10 19:28:44",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：2021年度权益分派10派2.5元 股权登记日为5月24日",
    "href": "http://stock.jrj.com.cn/2022/05/18203536660057.shtml",
    "datetime": "2022-05-18 20:35:36",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业5月6日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/05/06180536581840.shtml",
    "datetime": "2022-05-06 18:05:31",
    "code": "300584"
  },
  {
    "title": "海辰药业2022年第一季度净利1262.1万同比下滑6.58% 期内销售产品结构调整所致",
    "href": "http://stock.jrj.com.cn/2022/04/24161236447644.shtml",
    "datetime": "2022-04-24 16:12:19",
    "code": "300584"
  },
  {
    "title": "海辰药业2021年净利2.86亿同比增长417.61% 董事长曹于平薪酬41.14万",
    "href": "http://stock.jrj.com.cn/2022/04/21231236423042.shtml",
    "datetime": "2022-04-21 23:12:59",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：一季度报净利降6.58%至1262.1万元",
    "href": "http://stock.jrj.com.cn/2022/04/21164536419534.shtml",
    "datetime": "2022-04-21 16:45:25",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：2021年净利增417.61%至2.86亿元 拟10派2.5元",
    "href": "http://stock.jrj.com.cn/2022/04/21164336419541.shtml",
    "datetime": "2022-04-21 16:43:31",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：安庆汇辰减资至1.75亿元暨少数股东退出",
    "href": "http://stock.jrj.com.cn/2022/03/29212736158682.shtml",
    "datetime": "2022-03-29 21:27:38",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业3月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/22180334861441.shtml",
    "datetime": "2022-03-22 18:03:11",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：董事长曹于平及持股5%以上股东柳晓泉合计解质1013万股",
    "href": "http://stock.jrj.com.cn/2022/03/10160134808787.shtml",
    "datetime": "2022-03-10 16:01:02",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业3月8日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/08180134541914.shtml",
    "datetime": "2022-03-08 18:01:33",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业2月23日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/02/23180134447656.shtml",
    "datetime": "2022-02-23 18:01:44",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业2月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/02/22180234435302.shtml",
    "datetime": "2022-02-22 18:02:14",
    "code": "300584"
  },
  {
    "title": "A股异动 | 海辰药业一字涨停 抗新冠药奈玛特韦原料药及其关键中间体项目获备案",
    "href": "http://stock.jrj.com.cn/2022/02/21093534418068.shtml",
    "datetime": "2022-02-21 09:35:50",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：抗新冠药奈玛特韦原料药及其关键中间体项目获备案",
    "href": "http://stock.jrj.com.cn/2022/02/20215734415889.shtml",
    "datetime": "2022-02-20 21:57:33",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业2月9日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/02/09180234314033.shtml",
    "datetime": "2022-02-09 18:02:33",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业1月27日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/27180234231274.shtml",
    "datetime": "2022-01-27 18:02:12",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：消化类产品收入占比较小 对公司经营业绩影响很小",
    "href": "http://stock.jrj.com.cn/2022/01/27165934230813.shtml",
    "datetime": "2022-01-27 16:59:11",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业1月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/25180234213072.shtml",
    "datetime": "2022-01-25 18:02:31",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业1月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/21180234183430.shtml",
    "datetime": "2022-01-21 18:02:13",
    "code": "300584"
  },
  {
    "title": "海辰药业净利预增4倍年内股价翻番 公允价值变动收益贡献超九成利润",
    "href": "http://stock.jrj.com.cn/2022/01/21074134180842.shtml",
    "datetime": "2022-01-21 07:41:52",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业1月20日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/20180234179233.shtml",
    "datetime": "2022-01-20 18:02:41",
    "code": "300584"
  },
  {
    "title": "A股异动 | 海辰药业盘中涨15% 2021年净利同比预增422.09%~441.30%",
    "href": "http://stock.jrj.com.cn/2022/01/20095534177099.shtml",
    "datetime": "2022-01-20 09:55:41",
    "code": "300584"
  },
  {
    "title": "海辰药业2021年预计净利2.88亿-2.99亿 同比增长422%-441% 金融资产公允价值获利",
    "href": "http://stock.jrj.com.cn/2022/01/19181234174919.shtml",
    "datetime": "2022-01-19 18:12:04",
    "code": "300584"
  },
  {
    "title": "海辰药业：2021年归母净利预盈2.88亿至2.99亿元 同比预增422.09%-441.30%",
    "href": "http://stock.jrj.com.cn/2022/01/19165434174738.shtml",
    "datetime": "2022-01-19 16:54:15",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)2021年度扣非净利润预降30%-50%",
    "href": "http://stock.jrj.com.cn/2022/01/19154234174019.shtml",
    "datetime": "2022-01-19 15:42:31",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业1月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/18180234170448.shtml",
    "datetime": "2022-01-18 18:02:46",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业1月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/17180234165432.shtml",
    "datetime": "2022-01-17 18:02:40",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业1月13日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/13180234154811.shtml",
    "datetime": "2022-01-13 18:02:53",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业1月12日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/12180234150648.shtml",
    "datetime": "2022-01-12 18:02:13",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业1月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/11180234146847.shtml",
    "datetime": "2022-01-11 18:02:44",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：注射用艾司奥美拉唑钠通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/01/07161134133633.shtml",
    "datetime": "2022-01-07 16:11:51",
    "code": "300584"
  },
  {
    "title": "海辰药业董事长曹于平质押73万股 用于置换存量融资",
    "href": "http://stock.jrj.com.cn/2021/12/31193234094261.shtml",
    "datetime": "2021-12-31 19:32:50",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：董事长曹于平补充质押73万股及质押的492万股展期",
    "href": "http://stock.jrj.com.cn/2021/12/31164334093333.shtml",
    "datetime": "2021-12-31 16:43:13",
    "code": "300584"
  },
  {
    "title": "海辰药业：注射用兰索拉唑通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/12/16173734024889.shtml",
    "datetime": "2021-12-16 17:37:50",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：拟对第一期员工持股计划在原定终止日基础上延期12个月",
    "href": "http://stock.jrj.com.cn/2021/12/14162534014590.shtml",
    "datetime": "2021-12-14 16:25:06",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：注射用盐酸兰地洛尔列入国家医保目录",
    "href": "http://stock.jrj.com.cn/2021/12/03155533960167.shtml",
    "datetime": "2021-12-03 15:55:59",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：董事长曹于平解押430万股",
    "href": "http://stock.jrj.com.cn/2021/11/22160733903989.shtml",
    "datetime": "2021-11-22 16:07:31",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：董事长质押380万股、质押的150万股展期、补充质押40万股及解押450万股",
    "href": "http://stock.jrj.com.cn/2021/11/08220033824703.shtml",
    "datetime": "2021-11-08 22:00:59",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)第三季度净利润709.71万元 同比下降40.13%",
    "href": "http://stock.jrj.com.cn/2021/10/25191733748957.shtml",
    "datetime": "2021-10-25 19:17:53",
    "code": "300584"
  },
  {
    "title": "海辰药业股东柳晓泉质押638万股 用于个人投资",
    "href": "http://stock.jrj.com.cn/2021/09/09190633410778.shtml",
    "datetime": "2021-09-09 19:06:31",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：持股5%以上的柳晓泉质押638万股",
    "href": "http://stock.jrj.com.cn/2021/09/09164633409915.shtml",
    "datetime": "2021-09-09 16:46:40",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：持股5%以上的柳晓泉解押610万股",
    "href": "http://stock.jrj.com.cn/2021/09/08212033405995.shtml",
    "datetime": "2021-09-08 21:20:31",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：董事长曹于平解押150万股",
    "href": "http://stock.jrj.com.cn/2021/09/02155933374455.shtml",
    "datetime": "2021-09-02 15:59:21",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：持股5%以上的柳晓泉补充质押60万股",
    "href": "http://stock.jrj.com.cn/2021/09/01220733369864.shtml",
    "datetime": "2021-09-01 22:07:19",
    "code": "300584"
  },
  {
    "title": "海辰药业股东柳晓泉质押60万股 用于补充前期质押",
    "href": "http://stock.jrj.com.cn/2021/09/01193433369124.shtml",
    "datetime": "2021-09-01 19:34:11",
    "code": "300584"
  },
  {
    "title": "海辰药业2021年上半年净利2113.62万下滑42.07% 产品销量及销售收入下滑",
    "href": "http://stock.jrj.com.cn/2021/08/03213633197742.shtml",
    "datetime": "2021-08-03 21:36:35",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)半年度净利润降42.07%至2113.62万元",
    "href": "http://stock.jrj.com.cn/2021/08/03185433197163.shtml",
    "datetime": "2021-08-03 18:54:13",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：董事长曹于平质押375万股及解押470万股",
    "href": "http://stock.jrj.com.cn/2021/07/27195633159490.shtml",
    "datetime": "2021-07-27 19:56:55",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：口服抗凝药阿哌沙班片获批上市",
    "href": "http://stock.jrj.com.cn/2021/07/07155333058394.shtml",
    "datetime": "2021-07-07 15:53:32",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：恩替卡韦片获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2021/06/27172033002848.shtml",
    "datetime": "2021-06-27 17:20:40",
    "code": "300584"
  },
  {
    "title": "A股异动 | 海辰药业(300584.SZ)涨超7% 利伐沙班片(15mg、20mg)拟中选集采",
    "href": "http://stock.jrj.com.cn/2021/06/24102532987863.shtml",
    "datetime": "2021-06-24 10:25:14",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：利伐沙班片(15mg、20mg)拟中选集采",
    "href": "http://stock.jrj.com.cn/2021/06/23203032984887.shtml",
    "datetime": "2021-06-23 20:30:40",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：董事长曹于平质押300万股及解押270万股",
    "href": "http://stock.jrj.com.cn/2021/06/22163332976576.shtml",
    "datetime": "2021-06-22 16:33:59",
    "code": "300584"
  },
  {
    "title": "海辰药业控股股东曹于平质押158万股 用于补充质押",
    "href": "http://stock.jrj.com.cn/2021/05/13200732750244.shtml",
    "datetime": "2021-05-13 20:07:30",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：董事长曹于平补充质押158万股及质押的312万股延期购回",
    "href": "http://stock.jrj.com.cn/2021/05/13155532748481.shtml",
    "datetime": "2021-05-13 15:55:28",
    "code": "300584"
  },
  {
    "title": "海辰药业：公司原料药暂时没有出口的项目",
    "href": "http://stock.jrj.com.cn/2021/04/29101032478367.shtml",
    "datetime": "2021-04-29 10:10:59",
    "code": "300584"
  },
  {
    "title": "海辰药业：安庆汇辰原料药与医药中间体新建产能项目按照21年的工作计划预计2022年竣工投产",
    "href": "http://stock.jrj.com.cn/2021/04/12102632356252.shtml",
    "datetime": "2021-04-12 10:26:49",
    "code": "300584"
  },
  {
    "title": "海辰药业：兰地洛尔已经可以在山东、江西、广西、云南、海南等省份展开销售",
    "href": "http://stock.jrj.com.cn/2021/04/12102332356242.shtml",
    "datetime": "2021-04-12 10:23:30",
    "code": "300584"
  },
  {
    "title": "海辰药业：公司已经启动安庆汇辰药业医药原料药与中间体项目建设",
    "href": "http://stock.jrj.com.cn/2021/04/12102232356240.shtml",
    "datetime": "2021-04-12 10:22:08",
    "code": "300584"
  },
  {
    "title": "海辰药业：公司未来也计划在新药研发方面储备更多资源",
    "href": "http://stock.jrj.com.cn/2021/04/12101932356176.shtml",
    "datetime": "2021-04-12 10:19:27",
    "code": "300584"
  },
  {
    "title": "A股异动 | 海辰药业(300584.SZ)跌6.75% 2020年度净利润降43.21%",
    "href": "http://stock.jrj.com.cn/2021/04/08105432330763.shtml",
    "datetime": "2021-04-08 10:54:53",
    "code": "300584"
  },
  {
    "title": "海辰药业2021年第一季度净利下滑21.3% 政府补助款项减少",
    "href": "http://stock.jrj.com.cn/2021/04/07223932327913.shtml",
    "datetime": "2021-04-07 22:39:54",
    "code": "300584"
  },
  {
    "title": "海辰药业2020年净利下滑43.21% 董事长曹于平薪酬41.08万",
    "href": "http://stock.jrj.com.cn/2021/04/07223532327898.shtml",
    "datetime": "2021-04-07 22:35:28",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)2020年度净利润降43.21%至5523万元 拟10派1.25元",
    "href": "http://stock.jrj.com.cn/2021/04/07204632327352.shtml",
    "datetime": "2021-04-07 20:46:49",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)一季度净利润降21.30%至1350.99万元",
    "href": "http://stock.jrj.com.cn/2021/04/07204432327342.shtml",
    "datetime": "2021-04-07 20:44:18",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：替格瑞洛片获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2021/03/24154732208670.shtml",
    "datetime": "2021-03-24 15:47:56",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)获得高新技术企业证书",
    "href": "http://stock.jrj.com.cn/2021/03/22162632194633.shtml",
    "datetime": "2021-03-22 16:26:59",
    "code": "300584"
  },
  {
    "title": "海辰药业聘任钱佳玟为公司副总经理",
    "href": "http://stock.jrj.com.cn/2021/03/04194032072518.shtml",
    "datetime": "2021-03-04 19:40:04",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：达比加群酯胶囊注册申请获受理",
    "href": "http://stock.jrj.com.cn/2021/02/18155531986678.shtml",
    "datetime": "2021-02-18 15:55:50",
    "code": "300584"
  },
  {
    "title": "海辰药业董事长曹于平质押74万股 用于对意大利抗肿瘤药研发机构NMS的股权投资",
    "href": "http://stock.jrj.com.cn/2021/01/25222831769337.shtml",
    "datetime": "2021-01-25 22:28:15",
    "code": "300584"
  },
  {
    "title": "海辰药业控股股东曹于平质押205万股 用于置换存量融资",
    "href": "http://stock.jrj.com.cn/2021/01/15195131701040.shtml",
    "datetime": "2021-01-15 19:51:53",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：董事长曹于平质押205万股",
    "href": "http://stock.jrj.com.cn/2021/01/15172431699940.shtml",
    "datetime": "2021-01-15 17:24:50",
    "code": "300584"
  },
  {
    "title": "[海辰药业]乘风破浪 砥砺前行---海辰药业2021年度工作会议",
    "href": "http://stock.jrj.com.cn/2021/01/13000031688307.shtml",
    "datetime": "2021-01-13 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：公司兰地洛尔（泽醒）已经获得注册批件正在抓紧推进目标省份区域的物价备案、挂外招采等工作",
    "href": "http://stock.jrj.com.cn/2021/01/05135931633813.shtml",
    "datetime": "2021-01-05 13:59:34",
    "code": "300584"
  },
  {
    "title": "[海辰药业]喜报!海辰药业产品泽醒—注射用盐酸兰地洛尔上市",
    "href": "http://stock.jrj.com.cn/2020/12/22000031544878.shtml",
    "datetime": "2020-12-22 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：公司注射用盐酸兰地洛尔获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/12/20175631527237.shtml",
    "datetime": "2020-12-20 17:56:07",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：第一期员工持股计划延期暨变更",
    "href": "http://stock.jrj.com.cn/2020/12/14164931487644.shtml",
    "datetime": "2020-12-14 16:49:04",
    "code": "300584"
  },
  {
    "title": "A股异动 | 海辰药业(300584.SZ)午后直线拉升 对外投资公司获得药物临床试验批准",
    "href": "http://stock.jrj.com.cn/2020/11/17133331299668.shtml",
    "datetime": "2020-11-17 13:33:04",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：NMS集团PARP抑制剂NMS-03305293胶囊获批临床",
    "href": "http://stock.jrj.com.cn/2020/11/17131031299396.shtml",
    "datetime": "2020-11-17 13:10:19",
    "code": "300584"
  },
  {
    "title": "午间公告:海辰药业对外投资公司获得药物临床试验批准",
    "href": "http://stock.jrj.com.cn/2020/11/17120931298869.shtml",
    "datetime": "2020-11-17 12:09:36",
    "code": "300584"
  },
  {
    "title": "海辰药业控股股东曹于平质押180万股 占公司总股本1.5%",
    "href": "http://stock.jrj.com.cn/2020/11/09202831242929.shtml",
    "datetime": "2020-11-09 20:28:03",
    "code": "300584"
  },
  {
    "title": "海辰药业控股股东曹于平合计质押150万股 用于置换前期融资",
    "href": "http://stock.jrj.com.cn/2020/11/06200731232286.shtml",
    "datetime": "2020-11-06 20:07:22",
    "code": "300584"
  },
  {
    "title": "海辰药业2020年前三季度净利4834.03万下滑37.59% 投资收益减少",
    "href": "http://stock.jrj.com.cn/2020/10/30092431173280.shtml",
    "datetime": "2020-10-30 09:24:32",
    "code": "300584"
  },
  {
    "title": "海辰药业(300584.SZ)：前三季度净利降37.59%至4834.03万元",
    "href": "http://stock.jrj.com.cn/2020/10/29161431157910.shtml",
    "datetime": "2020-10-29 16:14:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：目前后续产品进展较快的有利伐沙班原料及片剂项目、阿哌沙班原料及片剂项目等",
    "href": "http://stock.jrj.com.cn/2020/10/26103931131734.shtml",
    "datetime": "2020-10-26 10:39:57",
    "code": "300584"
  },
  {
    "title": "[海辰药业]安徽海辰药业开工典礼暨奠基仪式",
    "href": "http://stock.jrj.com.cn/2020/09/28000030853623.shtml",
    "datetime": "2020-09-28 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：公司兰地洛尔原料及粉针项目目前处于药审中心审评流程中",
    "href": "http://stock.jrj.com.cn/2020/09/21172130803422.shtml",
    "datetime": "2020-09-21 17:21:59",
    "code": "300584"
  },
  {
    "title": "海辰药业投资案两人内幕交易 监事会主席配偶遭处罚",
    "href": "http://stock.jrj.com.cn/2020/08/26174330595200.shtml",
    "datetime": "2020-08-26 17:43:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]南京海辰药业迎来国家药品注册现场核查",
    "href": "http://stock.jrj.com.cn/2020/07/28000030362416.shtml",
    "datetime": "2020-07-28 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]海辰药业连续第二年登陆中国化药企业TOP100排行榜",
    "href": "http://stock.jrj.com.cn/2020/07/27000030355493.shtml",
    "datetime": "2020-07-27 00:00:00",
    "code": "300584"
  },
  {
    "title": "【龙虎榜】海辰药业7月24日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/24180730334798.shtml",
    "datetime": "2020-07-24 18:07:13",
    "code": "300584"
  },
  {
    "title": "[海辰药业]公益路漫漫 吾将上下而求索 ——庆祝海辰希望小学“六一”儿童节",
    "href": "http://stock.jrj.com.cn/2020/06/01000029826761.shtml",
    "datetime": "2020-06-01 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业股东曹于平质押700万股 用于股权投资",
    "href": "http://stock.jrj.com.cn/2020/05/12180929652029.shtml",
    "datetime": "2020-05-12 18:09:00",
    "code": "300584"
  },
  {
    "title": "海辰药业2020年一季度预计净利1559万元-1782万元 同比下降20%-30%",
    "href": "http://stock.jrj.com.cn/2020/04/08211029239468.shtml",
    "datetime": "2020-04-08 21:10:30",
    "code": "300584"
  },
  {
    "title": "海辰药业：预计一季度净利润下滑逾20%",
    "href": "http://stock.jrj.com.cn/2020/04/08174129238408.shtml",
    "datetime": "2020-04-08 17:41:00",
    "code": "300584"
  },
  {
    "title": "海辰药业子公司竞得一块地",
    "href": "http://stock.jrj.com.cn/2020/03/02223628937073.shtml",
    "datetime": "2020-03-02 22:36:40",
    "code": "300584"
  },
  {
    "title": "海辰药业2019年盈利9758万元增长17% 订单量保持较大增幅",
    "href": "http://stock.jrj.com.cn/2020/02/25204628892341.shtml",
    "datetime": "2020-02-25 20:46:30",
    "code": "300584"
  },
  {
    "title": "海辰药业2019年度净利同比增长17.25%",
    "href": "http://stock.jrj.com.cn/2020/02/25200828892170.shtml",
    "datetime": "2020-02-25 20:08:27",
    "code": "300584"
  },
  {
    "title": "海辰药业阿哌沙班片注册被受理 子公司NMS自有品种将成新增长点？",
    "href": "http://stock.jrj.com.cn/2020/02/19084428853403.shtml",
    "datetime": "2020-02-19 08:44:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：阿哌沙班片注册申请获受理",
    "href": "http://stock.jrj.com.cn/2020/02/18183328849585.shtml",
    "datetime": "2020-02-18 18:33:23",
    "code": "300584"
  },
  {
    "title": "海辰药业：阿哌沙班片注册申请获得受理",
    "href": "http://stock.jrj.com.cn/2020/02/18173628849338.shtml",
    "datetime": "2020-02-18 17:36:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]海辰药业“苯磺酸氨氯地平片”通过质量与疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2020/02/11000028810483.shtml",
    "datetime": "2020-02-11 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：司药品通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/02/10170428803683.shtml",
    "datetime": "2020-02-10 17:04:05",
    "code": "300584"
  },
  {
    "title": "[海辰药业]马秋林副省长到我司调研复工情况",
    "href": "http://stock.jrj.com.cn/2020/02/10000028804188.shtml",
    "datetime": "2020-02-10 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]栖霞区委书记黎辉莅临我司调研",
    "href": "http://stock.jrj.com.cn/2020/02/07000028794385.shtml",
    "datetime": "2020-02-07 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：部分产品市场需求增加 公司于2月3日复工生产",
    "href": "http://stock.jrj.com.cn/2020/02/03095128751526.shtml",
    "datetime": "2020-02-03 09:51:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]不忘初心 从头越 不辱使命 再出发 ---海辰药业2020年会",
    "href": "http://stock.jrj.com.cn/2020/01/21000030406379.shtml",
    "datetime": "2020-01-21 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]海辰药业2019年销售总结暨2020年销售工作部署大会成功召开",
    "href": "http://stock.jrj.com.cn/2020/01/20000028709145.shtml",
    "datetime": "2020-01-20 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业2019年度净利9155万元—9987万元 同比增长10%以上",
    "href": "http://stock.jrj.com.cn/2020/01/06172228631887.shtml",
    "datetime": "2020-01-06 17:22:24",
    "code": "300584"
  },
  {
    "title": "海辰药业：2019年度净利同比预增10%-20%",
    "href": "http://stock.jrj.com.cn/2020/01/06165328631725.shtml",
    "datetime": "2020-01-06 16:53:56",
    "code": "300584"
  },
  {
    "title": "海辰药业：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/06162028631591.shtml",
    "datetime": "2020-01-06 16:20:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]李军华大使访问意大利NMS集团",
    "href": "http://stock.jrj.com.cn/2019/12/19000028558054.shtml",
    "datetime": "2019-12-19 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]江苏省私营个体经济协会会员大会选举曹于平董事长担任第三届理事会副会长",
    "href": "http://stock.jrj.com.cn/2019/12/19000028558055.shtml",
    "datetime": "2019-12-19 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业实际控制人曹于平质押700万股 2019年上半年净利同比增长30%",
    "href": "http://stock.jrj.com.cn/2019/11/11182528381053.shtml",
    "datetime": "2019-11-11 18:25:59",
    "code": "300584"
  },
  {
    "title": "[海辰药业]曹董应邀出席南京药学会建会90周年纪念大会",
    "href": "http://stock.jrj.com.cn/2019/10/28000028310080.shtml",
    "datetime": "2019-10-28 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]江苏省危险废物产生单位信息公开表2019年第三季度",
    "href": "http://stock.jrj.com.cn/2019/10/25000028354209.shtml",
    "datetime": "2019-10-25 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业2019年前三季度营收6.85亿元 销售规模扩大所致",
    "href": "http://stock.jrj.com.cn/2019/10/22194928284303.shtml",
    "datetime": "2019-10-22 19:49:45",
    "code": "300584"
  },
  {
    "title": "海辰药业：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/08225028215312.shtml",
    "datetime": "2019-10-08 22:50:00",
    "code": "300584"
  },
  {
    "title": "海辰药业股东曹于平增持63万股 耗资约2035万元",
    "href": "http://stock.jrj.com.cn/2019/09/16205528136928.shtml",
    "datetime": "2019-09-16 20:55:06",
    "code": "300584"
  },
  {
    "title": "海辰药业拟签订《投资合作协议》 启动原料药与医药中间体子项目建设",
    "href": "http://stock.jrj.com.cn/2019/09/06084228100464.shtml",
    "datetime": "2019-09-06 08:42:59",
    "code": "300584"
  },
  {
    "title": "[海辰药业]“热血传情 情浓于血”海辰药业2019年无偿献血活动实记",
    "href": "http://stock.jrj.com.cn/2019/09/02000028074630.shtml",
    "datetime": "2019-09-02 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]“青春激昂 同舟共济 乘风破浪 再创辉煌” 海辰药业2019年新员工拓展纪实",
    "href": "http://stock.jrj.com.cn/2019/08/05000027931229.shtml",
    "datetime": "2019-08-05 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：2019年半年度报告主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/02220027923085.shtml",
    "datetime": "2019-08-02 22:00:01",
    "code": "300584"
  },
  {
    "title": "海辰药业：拟引进意大利Nerviano公司IDH抑制剂候选化合物",
    "href": "http://stock.jrj.com.cn/2019/08/02173927922057.shtml",
    "datetime": "2019-08-02 17:39:56",
    "code": "300584"
  },
  {
    "title": "海辰药业2019年上半年盈利5279万 实现企业平稳发展",
    "href": "http://stock.jrj.com.cn/2019/08/02170927922682.shtml",
    "datetime": "2019-08-02 17:09:17",
    "code": "300584"
  },
  {
    "title": "海辰药业：上半年净利5279万元 同比增长30%",
    "href": "http://stock.jrj.com.cn/2019/08/02163327921478.shtml",
    "datetime": "2019-08-02 16:33:15",
    "code": "300584"
  },
  {
    "title": "海辰药业：拟与意大利NMS集团签订《许可协议》 引进抑制剂候选化合物",
    "href": "http://stock.jrj.com.cn/2019/08/02163027921471.shtml",
    "datetime": "2019-08-02 16:30:42",
    "code": "300584"
  },
  {
    "title": "海辰药业：上半年净利5279万元 同比增30%",
    "href": "http://stock.jrj.com.cn/2019/08/02162727921639.shtml",
    "datetime": "2019-08-02 16:27:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]热烈祝贺我司入选“2018年度中国化药企业TOP100\"榜单",
    "href": "http://stock.jrj.com.cn/2019/07/17000027856970.shtml",
    "datetime": "2019-07-17 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]海辰药业2019年半年度销售会议成功召开",
    "href": "http://stock.jrj.com.cn/2019/07/11000027842543.shtml",
    "datetime": "2019-07-11 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]江苏省危险废物产生单位信息公开表 2019年第一、二季度",
    "href": "http://stock.jrj.com.cn/2019/07/11000027827660.shtml",
    "datetime": "2019-07-11 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]江苏省危险废物产生单位信息公开表 2019年第一、二季度",
    "href": "http://stock.jrj.com.cn/2019/07/10000028065111.shtml",
    "datetime": "2019-07-10 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]安庆市长莅临我司考察调研",
    "href": "http://stock.jrj.com.cn/2019/07/09000027819212.shtml",
    "datetime": "2019-07-09 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]2019年安全生产月之安全知识消防技能竞赛活动圆满落下帷幕",
    "href": "http://stock.jrj.com.cn/2019/07/03000027793935.shtml",
    "datetime": "2019-07-03 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业2019年上半年净利5496万 比上年同期增长35%",
    "href": "http://stock.jrj.com.cn/2019/07/02075427784119.shtml",
    "datetime": "2019-07-02 07:54:41",
    "code": "300584"
  },
  {
    "title": "海辰药业上半年净利润预增25%-35%",
    "href": "http://stock.jrj.com.cn/2019/07/01171327778956.shtml",
    "datetime": "2019-07-01 17:13:14",
    "code": "300584"
  },
  {
    "title": "海辰药业：上半年净利预增25%-35%",
    "href": "http://stock.jrj.com.cn/2019/07/01155427778666.shtml",
    "datetime": "2019-07-01 15:54:25",
    "code": "300584"
  },
  {
    "title": "海辰药业：参股公司新品获美国FDA临床试验资格",
    "href": "http://stock.jrj.com.cn/2019/06/25115627752337.shtml",
    "datetime": "2019-06-25 11:56:57",
    "code": "300584"
  },
  {
    "title": "[海辰药业]药融圈CBV精英莅临我司考察交流",
    "href": "http://stock.jrj.com.cn/2019/06/24000027748375.shtml",
    "datetime": "2019-06-24 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]意大利NMS集团下属NerPharMa公司总经理 Angelo Colombo 先生莅临我司工作交流",
    "href": "http://stock.jrj.com.cn/2019/06/18000027725645.shtml",
    "datetime": "2019-06-18 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]安庆市高新区管委会领导莅临海辰药业参观指导",
    "href": "http://stock.jrj.com.cn/2019/06/04000027664676.shtml",
    "datetime": "2019-06-04 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]喜报",
    "href": "http://stock.jrj.com.cn/2019/05/31000027654899.shtml",
    "datetime": "2019-05-31 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：收到利伐沙班片注册受理通知书",
    "href": "http://stock.jrj.com.cn/2019/05/09185427549197.shtml",
    "datetime": "2019-05-09 18:54:18",
    "code": "300584"
  },
  {
    "title": "海辰药业：利伐沙班片药品注册申请已被受理",
    "href": "http://stock.jrj.com.cn/2019/05/09174027548850.shtml",
    "datetime": "2019-05-09 17:40:52",
    "code": "300584"
  },
  {
    "title": "海辰药业：收到利伐沙班片药品注册受理通知书",
    "href": "http://stock.jrj.com.cn/2019/05/09171727548703.shtml",
    "datetime": "2019-05-09 17:17:00",
    "code": "300584"
  },
  {
    "title": "海辰药业一季度净利润同比增长31%",
    "href": "http://stock.jrj.com.cn/2019/04/11174127367940.shtml",
    "datetime": "2019-04-11 17:41:02",
    "code": "300584"
  },
  {
    "title": "海辰药业：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/04/03233027316844.shtml",
    "datetime": "2019-04-03 23:30:17",
    "code": "300584"
  },
  {
    "title": "海辰药业：一季度净利预增25%-35%",
    "href": "http://stock.jrj.com.cn/2019/04/03182627315560.shtml",
    "datetime": "2019-04-03 18:26:47",
    "code": "300584"
  },
  {
    "title": "海辰药业去年净利8322万同比增27% 董事长曹于平年薪41万元",
    "href": "http://stock.jrj.com.cn/2019/04/02074827303945.shtml",
    "datetime": "2019-04-02 07:48:14",
    "code": "300584"
  },
  {
    "title": "海辰药业：2018年年度报告主要财务指标及分配预案",
    "href": "http://stock.jrj.com.cn/2019/04/01204027296681.shtml",
    "datetime": "2019-04-01 20:40:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：2018年净利同比增27% 拟10派2元",
    "href": "http://stock.jrj.com.cn/2019/04/01171827294849.shtml",
    "datetime": "2019-04-01 17:18:36",
    "code": "300584"
  },
  {
    "title": "海辰药业：2018年净利同比增26.86% 拟10派2元",
    "href": "http://stock.jrj.com.cn/2019/04/01171027294787.shtml",
    "datetime": "2019-04-01 17:10:30",
    "code": "300584"
  },
  {
    "title": "[海辰药业]中国药科大学专家一行莅临我司参观指导",
    "href": "http://stock.jrj.com.cn/2019/03/27000027251059.shtml",
    "datetime": "2019-03-27 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]开展义务劳动 彰显党员风采",
    "href": "http://stock.jrj.com.cn/2019/03/26000027240425.shtml",
    "datetime": "2019-03-26 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]曹董应邀出席创新药研发高峰论坛",
    "href": "http://stock.jrj.com.cn/2019/03/18000027192066.shtml",
    "datetime": "2019-03-18 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业2018年利润8324万元增长27% 顺应医药产业变革",
    "href": "http://stock.jrj.com.cn/2019/02/26232427093869.shtml",
    "datetime": "2019-02-26 23:24:12",
    "code": "300584"
  },
  {
    "title": "海辰药业：2018净利润8.32亿元，同期增加26.88%",
    "href": "http://stock.jrj.com.cn/2019/02/26152127092113.shtml",
    "datetime": "2019-02-26 15:21:22",
    "code": "300584"
  },
  {
    "title": "午间公告：海辰药业2018年净利同比增26.88%",
    "href": "http://stock.jrj.com.cn/2019/02/26120727091384.shtml",
    "datetime": "2019-02-26 12:07:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]任凭风吹雨打,笑看云开日出",
    "href": "http://stock.jrj.com.cn/2019/01/29000027008023.shtml",
    "datetime": "2019-01-29 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]税岁送福 情满海辰",
    "href": "http://stock.jrj.com.cn/2019/01/18000026924490.shtml",
    "datetime": "2019-01-18 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/14200026902748.shtml",
    "datetime": "2019-01-14 20:00:10",
    "code": "300584"
  },
  {
    "title": "海辰药业2018年净利预增25%-30%",
    "href": "http://stock.jrj.com.cn/2019/01/14164926901922.shtml",
    "datetime": "2019-01-14 16:49:19",
    "code": "300584"
  },
  {
    "title": "海辰药业：2018年净利预增25%-30%",
    "href": "http://stock.jrj.com.cn/2019/01/14154726901716.shtml",
    "datetime": "2019-01-14 15:47:44",
    "code": "300584"
  },
  {
    "title": "[海辰药业]公司2018年销售总结暨2019年销售工作思路大会成功召开",
    "href": "http://stock.jrj.com.cn/2019/01/09000026879284.shtml",
    "datetime": "2019-01-09 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]南京海辰药业2018年第四季度危废信息公开表",
    "href": "http://stock.jrj.com.cn/2019/01/07000026866407.shtml",
    "datetime": "2019-01-07 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]获得注射用艾司奥美拉唑钠药品注册批件",
    "href": "http://stock.jrj.com.cn/2018/12/27000026812131.shtml",
    "datetime": "2018-12-27 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]我司粉针剂(头孢菌素类)、冻干粉针剂(6车间)药品GMP认证通过",
    "href": "http://stock.jrj.com.cn/2018/12/21000026811005.shtml",
    "datetime": "2018-12-21 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：获得注射用艾司奥美拉唑钠药品注册批件",
    "href": "http://stock.jrj.com.cn/2018/12/18160226759786.shtml",
    "datetime": "2018-12-18 16:02:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]市食药监局局长唐富春率队调研海辰药业",
    "href": "http://stock.jrj.com.cn/2018/12/17000026779376.shtml",
    "datetime": "2018-12-17 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]海辰药业助力中国药师周顺利召开",
    "href": "http://stock.jrj.com.cn/2018/11/22000025413308.shtml",
    "datetime": "2018-11-22 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]海辰药业第三季度危废信息公开表",
    "href": "http://stock.jrj.com.cn/2018/11/05000025305558.shtml",
    "datetime": "2018-11-05 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]海辰药业通过“省级技术中心认证”",
    "href": "http://stock.jrj.com.cn/2018/10/19000025227982.shtml",
    "datetime": "2018-10-19 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：前三季度净利预增30%-40%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/08075925167965.shtml",
    "datetime": "2018-10-08 07:59:53",
    "code": "300584"
  },
  {
    "title": "海辰药业：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/07215025164410.shtml",
    "datetime": "2018-10-07 21:50:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：前三季度净利润预增30%—40%",
    "href": "http://stock.jrj.com.cn/2018/10/07193025164266.shtml",
    "datetime": "2018-10-07 19:30:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]润东医药研发公司姜董来访",
    "href": "http://stock.jrj.com.cn/2018/08/30000025081677.shtml",
    "datetime": "2018-08-30 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]公司2018年半年度经营工作会议成功召开",
    "href": "http://stock.jrj.com.cn/2018/07/07000024826462.shtml",
    "datetime": "2018-07-07 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/07/02184024757591.shtml",
    "datetime": "2018-07-02 18:40:00",
    "code": "300584"
  },
  {
    "title": "海辰药业上半年业绩预增30%-40%",
    "href": "http://stock.jrj.com.cn/2018/07/02163224757061.shtml",
    "datetime": "2018-07-02 16:32:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：上半年净利预增30%-40%",
    "href": "http://stock.jrj.com.cn/2018/07/02161024756901.shtml",
    "datetime": "2018-07-02 16:10:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]南京海辰药业股份有限公司环境信息公开",
    "href": "http://stock.jrj.com.cn/2018/06/01000024625362.shtml",
    "datetime": "2018-06-01 00:00:00",
    "code": "300584"
  },
  {
    "title": "机构龙虎榜:医药股活跃不减 3机构买海辰药业3599万",
    "href": "http://stock.jrj.com.cn/hotstock/2018/05/25210324592747.shtml",
    "datetime": "2018-05-25 21:03:25",
    "code": "300584"
  },
  {
    "title": "[海辰药业]昆明市政府领导莅临海辰药业考察",
    "href": "http://stock.jrj.com.cn/2018/05/17000024569586.shtml",
    "datetime": "2018-05-17 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：注射用头孢西酮钠进入安徽省医保目录",
    "href": "http://stock.jrj.com.cn/2018/05/16162524548799.shtml",
    "datetime": "2018-05-16 16:25:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]2018.05南京海辰药业江苏省危险废物产生单位信息公开表",
    "href": "http://stock.jrj.com.cn/2018/05/08000024509827.shtml",
    "datetime": "2018-05-08 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业出海并购 欲试水新药研发",
    "href": "http://stock.jrj.com.cn/2018/04/10040924365089.shtml",
    "datetime": "2018-04-10 04:09:49",
    "code": "300584"
  },
  {
    "title": "[华西股份]华西股份、海辰药业等联合方完成对意大利老牌肿瘤药研发机构NMS集团90%股权并购",
    "href": "http://stock.jrj.com.cn/2018/03/30000024457788.shtml",
    "datetime": "2018-03-30 00:00:00",
    "code": "300584"
  },
  {
    "title": "华西股份、海辰药业联合完成并购海外肿瘤药企",
    "href": "http://stock.jrj.com.cn/2018/03/29224624324627.shtml",
    "datetime": "2018-03-29 22:46:33",
    "code": "300584"
  },
  {
    "title": "[海辰药业]中国药科大学校领导莅临海辰药业考察交流",
    "href": "http://stock.jrj.com.cn/2018/03/25000024299332.shtml",
    "datetime": "2018-03-25 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：2017年年度报告主要财务指标及分配预案",
    "href": "http://stock.jrj.com.cn/2018/03/11165024222716.shtml",
    "datetime": "2018-03-11 16:50:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：2018年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/03/11164024222703.shtml",
    "datetime": "2018-03-11 16:40:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：去年净利增45% 拟10转5派2.5元",
    "href": "http://stock.jrj.com.cn/2018/03/11162024222675.shtml",
    "datetime": "2018-03-11 16:20:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]南京引光医药公司总经理李正奇莅临我公司技术交流",
    "href": "http://stock.jrj.com.cn/2018/02/01000024180606.shtml",
    "datetime": "2018-02-01 00:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]合肥肥东县领导莅临海辰药业调研",
    "href": "http://stock.jrj.com.cn/2018/01/18000023991022.shtml",
    "datetime": "2018-01-18 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：2017年净利预增逾4成",
    "href": "http://stock.jrj.com.cn/hotstock/2018/01/15080023944743.shtml",
    "datetime": "2018-01-15 08:00:00",
    "code": "300584"
  },
  {
    "title": "[海辰药业]上善若水、大爱栖霞",
    "href": "http://stock.jrj.com.cn/2017/12/26000023857838.shtml",
    "datetime": "2017-12-26 00:00:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：重点产品入选黑龙江省医保目录",
    "href": "http://stock.jrj.com.cn/2017/12/07171523757482.shtml",
    "datetime": "2017-12-07 17:15:00",
    "code": "300584"
  },
  {
    "title": "海辰药业拟参与收购意大利医疗集团NMS",
    "href": "http://stock.jrj.com.cn/2017/11/26212123697155.shtml",
    "datetime": "2017-11-26 21:21:00",
    "code": "300584"
  },
  {
    "title": "公告精选：哈空调控股股东终止转让公司股权；海辰药业参与收购意大利医疗集团NMS",
    "href": "http://stock.jrj.com.cn/2017/11/26193523696993.shtml",
    "datetime": "2017-11-26 19:35:00",
    "code": "300584"
  },
  {
    "title": "海辰药业拟与合作方共同投资 收购意大利医疗集团90%股权",
    "href": "http://stock.jrj.com.cn/2017/11/26192823696990.shtml",
    "datetime": "2017-11-26 19:28:00",
    "code": "300584"
  },
  {
    "title": "海辰药业：参与收购意大利医疗集团NMS",
    "href": "http://stock.jrj.com.cn/2017/11/26191023696949.shtml",
    "datetime": "2017-11-26 19:10:00",
    "code": "300584"
  },
  {
    "title": "海辰药业网上申购中签号出炉共40000个 4日缴款",
    "href": "http://stock.jrj.com.cn/2017/01/03190921920975.shtml",
    "datetime": "2017-01-03 19:09:31",
    "code": "300584"
  },
  {
    "title": "贝斯特网上申购中签号出炉共90000个 4日缴款",
    "href": "http://stock.jrj.com.cn/2017/01/03190821920974.shtml",
    "datetime": "2017-01-03 19:08:23",
    "code": "300584"
  },
  {
    "title": "贝斯特网上发行最终中签率0.0406% 神器助力防弃购",
    "href": "http://stock.jrj.com.cn/ipo/2017/01/02172321915779.shtml",
    "datetime": "2017-01-02 17:23:18",
    "code": "300584"
  }
]